Cecha
Little lower jaw
Nazwa kliniczna: Micrognathia
Developmental hypoplasia of the mandible.
Podsumowanie
- Znana także jako
- Small jaw, Small lower jaw, Decreased size of lower jaw, Decreased size of mandible, Hypoplasia of lower jaw, Hypoplasia of mandible, Hypoplastic mandible, Hypoplastic mandible condyle, Hypotrophic lower jaw, Hypotrophic mandible, Little mandible, Lower jaw deficiency, Lower jaw hypoplasia, Mandibular deficiency, Mandibular hypoplasia, Mandibular micrognathia, Micrognathia of lower jaw, Micromandible, Robin mandible, Severe hypoplasia of mandible, Small mandible, Underdevelopment of lower jaw, Underdevelopment of mandible
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Little lower jaw, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test834 genów powiązanych z Little lower jaw
Zmiany w tych genach powodują rzadkie choroby, w których występuje Little lower jaw. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ALG1ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase | Zawsze | W 1 chorobie |
| ALG9ALG9 alpha-1,2-mannosyltransferase | Zawsze | W 2 chorobach |
| AMMECR1AMMECR nuclear protein 1 | Zawsze | W 1 chorobie |
| AMOTL1angiomotin like 1 | Zawsze | W 1 chorobie |
| ANTXR1ANTXR cell adhesion molecule 1 | Zawsze | W 2 chorobach |
| ARCN1archain 1 coat protein complex I subunit delta | Zawsze | W 1 chorobie |
| ARID2AT-rich interaction domain 2 | Zawsze | W 1 chorobie |
| ASPMassembly factor for spindle microtubules | Zawsze | W 1 chorobie |
| ATPAF2ATP synthase mitochondrial F1 complex assembly factor 2 | Zawsze | W 1 chorobie |
| B3GALT6beta-1,3-galactosyltransferase 6 | Zawsze | W 3 chorobach |
| BANF1barrier to autointegration nuclear assembly factor 1 | Zawsze | W 1 chorobie |
| BLTP1bridge-like lipid transfer protein family member 1 | Zawsze | W 1 chorobie |
| BPNT23'(2'), 5'-bisphosphate nucleotidase 2 | Zawsze | W 1 chorobie |
| CACNA1Ccalcium voltage-gated channel subunit alpha1 C | Zawsze | W 1 chorobie |
| CDC6cell division cycle 6 | Zawsze | W 2 chorobach |
| CDK5cyclin dependent kinase 5 | Zawsze | W 1 chorobie |
| CEP152centrosomal protein 152 | Zawsze | W 2 chorobach |
| CEP57centrosomal protein 57 | Zawsze | W 2 chorobach |
| CHASERRCHD2 adjacent suppressive regulatory RNA | Zawsze | W 1 chorobie |
| CHUKcomponent of inhibitor of nuclear factor kappa B kinase complex | Zawsze | W 1 chorobie |
| CILK1ciliogenesis associated kinase 1 | Zawsze | W 1 chorobie |
| CIROZciliated left-right organizer protein containing ZP-N domains | Zawsze | W 1 chorobie |
| CNOT2CCR4-NOT transcription complex subunit 2 | Zawsze | W 1 chorobie |
| COG1component of oligomeric golgi complex 1 | Zawsze | W 2 chorobach |
| COG7component of oligomeric golgi complex 7 | Zawsze | W 2 chorobach |
| COL13A1collagen type XIII alpha 1 chain | Zawsze | W 1 chorobie |
| COL6A2collagen type VI alpha 2 chain | Zawsze | W 2 chorobach |
| CPEcarboxypeptidase E | Zawsze | W 1 chorobie |
| CRNKL1crooked neck pre-mRNA splicing factor 1 | Zawsze | W 1 chorobie |
| CTCFCCCTC-binding factor | Zawsze | W 1 chorobie |
| CTU2cytosolic thiouridylase subunit 2 | Zawsze | W 1 chorobie |
| DCHS1dachsous cadherin-related 1 | Zawsze | W 2 chorobach |
| DNA2DNA replication helicase/nuclease 2 | Zawsze | W 2 chorobach |
| DPH1diphthamide biosynthesis 1 | Zawsze | W 2 chorobach |
| EBPEBP cholestenol delta-isomerase | Zawsze | W 2 chorobach |
| EFEMP2EGF-like fibulin extracellular matrix protein 2 | Zawsze | W 1 chorobie |
| EIF4A2eukaryotic translation initiation factor 4A2 | Zawsze | W 1 chorobie |
| EIF4A3eukaryotic translation initiation factor 4A3 | Zawsze | W 1 chorobie |
| ERCC1ERCC excision repair 1, endonuclease non-catalytic subunit | Zawsze | W 2 chorobach |
| ERCC2ERCC excision repair 2, TFIIH core complex helicase subunit | Zawsze | W 2 chorobach |
Pokaż jeszcze 794 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ERI1exoribonuclease 1 | Zawsze | W 1 chorobie |
| FBXO28F-box protein 28 | Zawsze | W 1 chorobie |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Zawsze | W 1 chorobie |
| FLNAfilamin A | Zawsze | W 6 chorobach |
| FLNBfilamin B | Zawsze | W 4 chorobach |
| FLVCR1FLVCR choline and heme transporter 1 | Zawsze | W 1 chorobie |
| GJA1gap junction protein alpha 1 | Zawsze | W 2 chorobach |
| GOLGA2golgin A2 | Zawsze | W 1 chorobie |
| GRIP1glutamate receptor interacting protein 1 | Zawsze | W 1 chorobie |
| GSCgoosecoid homeobox | Zawsze | W 1 chorobie |
| HSPG2heparan sulfate proteoglycan 2 | Zawsze | W 4 chorobach |
| HYLS1HYLS1 centriolar and ciliogenesis associated | Zawsze | W 2 chorobach |
| HYOU1hypoxia up-regulated 1 | Zawsze | W 1 chorobie |
| IARS2isoleucyl-tRNA synthetase 2, mitochondrial | Zawsze | W 1 chorobie |
| IFT140intraflagellar transport 140 | Zawsze | W 1 chorobie |
| IGF1insulin like growth factor 1 | Zawsze | W 2 chorobach |
| INPP4Ainositol polyphosphate-4-phosphatase type I A | Zawsze | W 1 chorobie |
| INTUinturned planar cell polarity protein | Zawsze | W 1 chorobie |
| JKAMPJNK1/MAPK8 associated membrane protein | Zawsze | W 1 chorobie |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Zawsze | W 2 chorobach |
| KCNK3potassium two pore domain channel subfamily K member 3 | Zawsze | W 1 chorobie |
| KCNK4potassium two pore domain channel subfamily K member 4 | Zawsze | W 1 chorobie |
| KDM6Blysine demethylase 6B | Zawsze | W 1 chorobie |
| LGI4leucine rich repeat LGI family member 4 | Zawsze | W 1 chorobie |
| LMNAlamin A/C | Zawsze | W 6 chorobach |
| MAD1L1mitotic arrest deficient 1 like 1 | Zawsze | W 1 chorobie |
| MAFBMAF bZIP transcription factor B | Zawsze | W 3 chorobach |
| MARS1methionyl-tRNA synthetase 1 | Zawsze | W 1 chorobie |
| MAU2MAU2 sister chromatid cohesion factor | Zawsze | W 2 chorobach |
| MCM5minichromosome maintenance complex component 5 | Zawsze | W 1 chorobie |
| MED12mediator complex subunit 12 | Zawsze | W 5 chorobach |
| MED16mediator complex subunit 16 | Zawsze | W 1 chorobie |
| MSL2MSL complex subunit 2 | Zawsze | W 1 chorobie |
| MYH3myosin heavy chain 3 | Zawsze | W 3 chorobach |
| MYMKmyomaker, myoblast fusion factor | Zawsze | W 2 chorobach |
| MYMXmyomixer, myoblast fusion factor | Zawsze | W 2 chorobach |
| NALCNsodium leak channel, non-selective | Zawsze | W 4 chorobach |
| NBNnibrin | Zawsze | W 1 chorobie |
| NECTIN1nectin cell adhesion molecule 1 | Zawsze | W 2 chorobach |
| NFASCneurofascin | Zawsze | W 1 chorobie |
| NOTCH3notch receptor 3 | Zawsze | W 3 chorobach |
| NR6A1nuclear receptor subfamily 6 group A member 1 | Zawsze | W 1 chorobie |
| NSD2nuclear receptor binding SET domain protein 2 | Zawsze | W 3 chorobach |
| NUP107nucleoporin 107 | Zawsze | W 3 chorobach |
| NUP88nucleoporin 88 | Zawsze | W 2 chorobach |
| NXNnucleoredoxin | Zawsze | W 2 chorobach |
| ORC4origin recognition complex subunit 4 | Zawsze | W 2 chorobach |
| ORC6origin recognition complex subunit 6 | Zawsze | W 2 chorobach |
| PAK2p21 (RAC1) activated kinase 2 | Zawsze | W 1 chorobie |
| PAN2poly(A) specific ribonuclease subunit PAN2 | Zawsze | W 1 chorobie |
| PEX1peroxisomal biogenesis factor 1 | Zawsze | W 2 chorobach |
| PEX14peroxisomal biogenesis factor 14 | Zawsze | W 2 chorobach |
| PI4KAphosphatidylinositol 4-kinase alpha | Zawsze | W 3 chorobach |
| PIEZO2piezo type mechanosensitive ion channel component 2 | Zawsze | W 3 chorobach |
| PIGQphosphatidylinositol glycan anchor biosynthesis class Q | Zawsze | W 1 chorobie |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Zawsze | W 1 chorobie |
| PLCB4phospholipase C beta 4 | Zawsze | W 3 chorobach |
| PLVAPplasmalemma vesicle associated protein | Zawsze | W 1 chorobie |
| POLD1DNA polymerase delta 1, catalytic subunit | Zawsze | W 1 chorobie |
| POLR1CRNA polymerase I and III subunit C | Zawsze | W 2 chorobach |
| POLR3ARNA polymerase III subunit A | Zawsze | W 1 chorobie |
| POMGNT1protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | Zawsze | W 1 chorobie |
| PPP3CAprotein phosphatase 3 catalytic subunit alpha | Zawsze | W 2 chorobach |
| PSAT1phosphoserine aminotransferase 1 | Zawsze | W 2 chorobach |
| PSMC1proteasome 26S subunit, ATPase 1 | Zawsze | W 1 chorobie |
| PTH1Rparathyroid hormone 1 receptor | Zawsze | W 4 chorobach |
| RAC3Rac family small GTPase 3 | Zawsze | W 1 chorobie |
| RAPSNreceptor associated protein of the synapse | Zawsze | W 2 chorobach |
| RBBP8RB binding protein 8, endonuclease | Zawsze | W 2 chorobach |
| RBM10RNA binding motif protein 10 | Zawsze | W 2 chorobach |
| RECQL4RecQ like helicase 4 | Zawsze | W 3 chorobach |
| RIN2Ras and Rab interactor 2 | Zawsze | W 1 chorobie |
| RIPK4receptor interacting serine/threonine kinase 4 | Zawsze | W 2 chorobach |
| RNU5B-1RNA, U5B small nuclear 1 | Zawsze | W 1 chorobie |
| ROBO1roundabout guidance receptor 1 | Zawsze | W 1 chorobie |
| RPS28ribosomal protein S28 | Zawsze | W 2 chorobach |
| RYR3ryanodine receptor 3 | Zawsze | W 1 chorobie |
| SATB2SATB homeobox 2 | Zawsze | W 4 chorobach |
| SC5Dsterol-C5-desaturase | Zawsze | W 2 chorobach |
| SCARF2scavenger receptor class F member 2 | Zawsze | W 2 chorobach |
| SCYL2SCY1 like pseudokinase 2 | Zawsze | W 2 chorobach |
| SEC31ASEC31 homolog A, COPII component | Zawsze | W 1 chorobie |
| SERPINH1serpin family H member 1 | Zawsze | W 1 chorobie |
| SETD2SET domain containing 2, histone lysine methyltransferase | Zawsze | W 1 chorobie |
| SLC37A4solute carrier family 37 member 4 | Zawsze | W 1 chorobie |
| SOX9SRY-box transcription factor 9 | Zawsze | W 3 chorobach |
| SP7Sp7 transcription factor | Zawsze | W 1 chorobie |
| SPOUT1SPOUT domain containing methyltransferase 1 | Zawsze | W 1 chorobie |
| SPRTNSprT-like N-terminal domain | Zawsze | W 1 chorobie |
| STAC3SH3 and cysteine rich domain 3 | Zawsze | W 2 chorobach |
| TBCEtubulin folding cofactor E | Zawsze | W 2 chorobach |
| TBX5T-box transcription factor 5 | Zawsze | W 1 chorobie |
| TCOF1treacle ribosome biogenesis factor 1 | Zawsze | W 2 chorobach |
| TCP1t-complex 1 | Zawsze | W 1 chorobie |
| TGDSTDP-glucose 4,6-dehydratase | Zawsze | W 2 chorobach |
| THOC2THO complex subunit 2 | Zawsze | W 1 chorobie |
| TM2D3TM2 domain containing 3 | Zawsze | W 1 chorobie |
| TOMM7translocase of outer mitochondrial membrane 7 | Zawsze | W 1 chorobie |
| TOP2BDNA topoisomerase II beta | Zawsze | W 1 chorobie |
| TOR1Atorsin family 1 member A | Zawsze | W 1 chorobie |
| TRAIPTRAF interacting protein | Zawsze | W 2 chorobach |
| TSR2TSR2 ribosome maturation factor | Zawsze | W 2 chorobach |
| UBE3Bubiquitin protein ligase E3B | Zawsze | W 2 chorobach |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Zawsze | W 1 chorobie |
| VPS13Bvacuolar protein sorting 13 homolog B | Zawsze | W 2 chorobach |
| VPS35LVPS35 endosomal protein sorting factor like | Zawsze | W 2 chorobach |
| VPS53VPS53 subunit of GARP complex | Zawsze | W 1 chorobie |
| ZMPSTE24zinc metallopeptidase STE24 | Zawsze | W 5 chorobach |
| ACTBactin beta | Bardzo często (80–99%) | W 1 chorobie |
| ACTG1actin gamma 1 | Bardzo często (80–99%) | W 1 chorobie |
| ADAMTS2ADAM metallopeptidase with thrombospondin type 1 motif 2 | Bardzo często (80–99%) | W 2 chorobach |
| ALX4ALX homeobox 4 | Bardzo często (80–99%) | W 1 chorobie |
| ANK1ankyrin 1 | Bardzo często (80–99%) | W 1 chorobie |
| ATRATR checkpoint kinase | Bardzo często (80–99%) | W 2 chorobach |
| ATRIPATR interacting protein | Bardzo często (80–99%) | W 1 chorobie |
| B3GLCTbeta 3-glucosyltransferase | Bardzo często (80–99%) | W 2 chorobach |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Bardzo często (80–99%) | W 1 chorobie |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Bardzo często (80–99%) | W 3 chorobach |
| BRD4bromodomain containing 4 | Bardzo często (80–99%) | W 1 chorobie |
| BRPF1bromodomain and PHD finger containing 1 | Bardzo często (80–99%) | W 1 chorobie |
| BUB1BUB1 mitotic checkpoint serine/threonine kinase | Bardzo często (80–99%) | W 1 chorobie |
| BUB1BBUB1 mitotic checkpoint serine/threonine kinase B | Bardzo często (80–99%) | W 2 chorobach |
| BUB3BUB3 mitotic checkpoint protein | Bardzo często (80–99%) | W 1 chorobie |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Bardzo często (80–99%) | W 1 chorobie |
| CBLCbl proto-oncogene | Bardzo często (80–99%) | W 1 chorobie |
| CD96CD96 molecule | Bardzo często (80–99%) | W 2 chorobach |
| CDC45cell division cycle 45 | Bardzo często (80–99%) | W 1 chorobie |
| CDCA7cell division cycle associated 7 | Bardzo często (80–99%) | W 1 chorobie |
| CDKN1Ccyclin dependent kinase inhibitor 1C | Bardzo często (80–99%) | W 1 chorobie |
| CDT1chromatin licensing and DNA replication factor 1 | Bardzo często (80–99%) | W 2 chorobach |
| CENPEcentromere protein E | Bardzo często (80–99%) | W 2 chorobach |
| CEP295centrosomal protein 295 | Bardzo często (80–99%) | W 2 chorobach |
| CEP63centrosomal protein 63 | Bardzo często (80–99%) | W 1 chorobie |
| CLIP2CAP-Gly domain containing linker protein 2 | Bardzo często (80–99%) | W 1 chorobie |
| COG4component of oligomeric golgi complex 4 | Bardzo często (80–99%) | W 1 chorobie |
| COL11A1collagen type XI alpha 1 chain | Bardzo często (80–99%) | W 3 chorobach |
| CPAPcentrosome assembly and centriole elongation protein | Bardzo często (80–99%) | W 1 chorobie |
| CPLX1complexin 1 | Bardzo często (80–99%) | W 2 chorobach |
| CREBBPCREB binding lysine acetyltransferase | Bardzo często (80–99%) | W 3 chorobach |
| CRTAPcartilage associated protein | Bardzo często (80–99%) | W 1 chorobie |
| CTBP1C-terminal binding protein 1 | Bardzo często (80–99%) | W 2 chorobach |
| CTDP1CTD phosphatase 1 | Bardzo często (80–99%) | W 1 chorobie |
| CWC27CWC27 spliceosome associated cyclophilin | Bardzo często (80–99%) | W 2 chorobach |
| DDX3XDEAD-box helicase 3 X-linked | Bardzo często (80–99%) | W 1 chorobie |
| DHCR2424-dehydrocholesterol reductase | Bardzo często (80–99%) | W 2 chorobach |
| DHCR77-dehydrocholesterol reductase | Bardzo często (80–99%) | W 2 chorobach |
| DHODHdihydroorotate dehydrogenase (quinone) | Bardzo często (80–99%) | W 2 chorobach |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Bardzo często (80–99%) | W 2 chorobach |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Bardzo często (80–99%) | W 1 chorobie |
| DNMT3BDNA methyltransferase 3 beta | Bardzo często (80–99%) | W 2 chorobach |
| DOK7docking protein 7 | Bardzo często (80–99%) | W 2 chorobach |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Bardzo często (80–99%) | W 1 chorobie |
| EFTUD2elongation factor Tu GTP binding domain containing 2 | Bardzo często (80–99%) | W 2 chorobach |
| EIF4Heukaryotic translation initiation factor 4H | Bardzo często (80–99%) | W 1 chorobie |
| ELNelastin | Bardzo często (80–99%) | W 1 chorobie |
| EMG1EMG1 N1-specific pseudouridine methyltransferase | Bardzo często (80–99%) | W 2 chorobach |
| EP300EP300 lysine acetyltransferase | Bardzo często (80–99%) | W 4 chorobach |
| ERCC5ERCC excision repair 5, endonuclease | Bardzo często (80–99%) | W 2 chorobach |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Bardzo często (80–99%) | W 2 chorobach |
| ERMARDER membrane associated RNA degradation | Bardzo często (80–99%) | W 1 chorobie |
| EXT2exostosin glycosyltransferase 2 | Bardzo często (80–99%) | W 1 chorobie |
| EXTL3exostosin like glycosyltransferase 3 | Bardzo często (80–99%) | W 2 chorobach |
| EZH2enhancer of zeste 2 polycomb repressive complex 2 subunit | Bardzo często (80–99%) | W 1 chorobie |
| FAM20CFAM20C golgi associated secretory pathway kinase | Bardzo często (80–99%) | W 2 chorobach |
| FBN1fibrillin 1 | Bardzo często (80–99%) | W 3 chorobach |
| FGFR2fibroblast growth factor receptor 2 | Bardzo często (80–99%) | W 3 chorobach |
| FIG4FIG4 phosphoinositide 5-phosphatase | Bardzo często (80–99%) | W 2 chorobach |
| FILIP1filamin A interacting protein 1 | Bardzo często (80–99%) | W 1 chorobie |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Bardzo często (80–99%) | W 1 chorobie |
| GHRgrowth hormone receptor | Bardzo często (80–99%) | W 1 chorobie |
| GLDNgliomedin | Bardzo często (80–99%) | W 1 chorobie |
| GLE1GLE1 RNA export mediator | Bardzo często (80–99%) | W 3 chorobach |
| GMNNgeminin DNA replication inhibitor | Bardzo często (80–99%) | W 1 chorobie |
| GRB10growth factor receptor bound protein 10 | Bardzo często (80–99%) | W 1 chorobie |
| GTF2Igeneral transcription factor IIi | Bardzo często (80–99%) | W 1 chorobie |
| GTF2IRD1GTF2I repeat domain containing 1 | Bardzo często (80–99%) | W 1 chorobie |
| GTF2IRD2GTF2I repeat domain containing 2 | Bardzo często (80–99%) | W 1 chorobie |
| HDAC8histone deacetylase 8 | Bardzo często (80–99%) | W 3 chorobach |
| HELLShelicase, lymphoid specific | Bardzo często (80–99%) | W 1 chorobie |
| HMGA2high mobility group AT-hook 2 | Bardzo często (80–99%) | W 2 chorobach |
| HYMAIhydatidiform mole associated and imprinted | Bardzo często (80–99%) | W 1 chorobie |
| IGF2insulin like growth factor 2 | Bardzo często (80–99%) | W 2 chorobach |
| IRF6interferon regulatory factor 6 | Bardzo często (80–99%) | W 1 chorobie |
| KAT6Blysine acetyltransferase 6B | Bardzo często (80–99%) | W 4 chorobach |
| KCNJ6potassium inwardly rectifying channel subfamily J member 6 | Bardzo często (80–99%) | W 2 chorobach |
| KIF21Akinesin family member 21A | Bardzo często (80–99%) | W 1 chorobie |
| KIF7kinesin family member 7 | Bardzo często (80–99%) | W 3 chorobach |
| KRASKRas proto-oncogene, GTPase | Bardzo często (80–99%) | W 2 chorobach |
| LAS1LLAS1 like ribosome biogenesis factor | Bardzo często (80–99%) | W 1 chorobie |
| LETM1leucine zipper and EF-hand containing transmembrane protein 1 | Bardzo często (80–99%) | W 3 chorobach |
| LIFRLIF receptor subunit alpha | Bardzo często (80–99%) | W 1 chorobie |
| LIMK1LIM domain kinase 1 | Bardzo często (80–99%) | W 1 chorobie |
| LZTR1leucine zipper like post translational regulator 1 | Bardzo często (80–99%) | W 2 chorobach |
| MAGEL2MAGE family member L2 | Bardzo często (80–99%) | W 1 chorobie |
| MAN2C1mannosidase alpha class 2C member 1 | Bardzo często (80–99%) | W 1 chorobie |
| MAP3K7mitogen-activated protein kinase kinase kinase 7 | Bardzo często (80–99%) | W 1 chorobie |
| METTL27methyltransferase like 27 | Bardzo często (80–99%) | W 1 chorobie |
| MRASmuscle RAS oncogene homolog | Bardzo często (80–99%) | W 1 chorobie |
| MUSKmuscle associated receptor tyrosine kinase | Bardzo często (80–99%) | W 2 chorobach |
| MYOD1myogenic differentiation 1 | Bardzo często (80–99%) | W 1 chorobie |
| NCF1neutrophil cytosolic factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| NELFAnegative elongation factor complex member A | Bardzo często (80–99%) | W 1 chorobie |
| NINninein | Bardzo często (80–99%) | W 1 chorobie |
| NIPBLNIPBL cohesin loading factor | Bardzo często (80–99%) | W 2 chorobach |
| NOTCH2notch receptor 2 | Bardzo często (80–99%) | W 2 chorobach |
| NRASNRAS proto-oncogene, GTPase | Bardzo często (80–99%) | W 1 chorobie |
| NSD1nuclear receptor binding SET domain protein 1 | Bardzo często (80–99%) | W 1 chorobie |
| NSMCE2NSE2 SUMO ligase component of SMC5/6 complex | Bardzo często (80–99%) | W 2 chorobach |
| NUP85nucleoporin 85 | Bardzo często (80–99%) | W 1 chorobie |
| ORC1origin recognition complex subunit 1 | Bardzo często (80–99%) | W 2 chorobach |
| P4HBprolyl 4-hydroxylase subunit beta | Bardzo często (80–99%) | W 2 chorobach |
| PCNTpericentrin | Bardzo często (80–99%) | W 1 chorobie |
| PHF21APHD finger protein 21A | Bardzo często (80–99%) | W 1 chorobie |
| PIGGphosphatidylinositol glycan anchor biosynthesis class G (EMM blood group) | Bardzo często (80–99%) | W 1 chorobie |
| PIGNphosphatidylinositol glycan anchor biosynthesis class N | Bardzo często (80–99%) | W 2 chorobach |
| PLAG1PLAG1 zinc finger | Bardzo często (80–99%) | W 1 chorobie |
| PLAGL1PLAG1 like zinc finger 1 | Bardzo często (80–99%) | W 1 chorobie |
| PLK4polo like kinase 4 | Bardzo często (80–99%) | W 2 chorobach |
| POLR1BRNA polymerase I subunit B | Bardzo często (80–99%) | W 2 chorobach |
| POLR1DRNA polymerase I and III subunit D | Bardzo często (80–99%) | W 2 chorobach |
| PQBP1polyglutamine binding protein 1 | Bardzo często (80–99%) | W 2 chorobach |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Bardzo często (80–99%) | W 2 chorobach |
| PUS1pseudouridine synthase 1 | Bardzo często (80–99%) | W 2 chorobach |
| RAD21RAD21 cohesin complex component | Bardzo często (80–99%) | W 1 chorobie |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Bardzo często (80–99%) | W 1 chorobie |
| RASA2RAS p21 protein activator 2 | Bardzo często (80–99%) | W 1 chorobie |
| RFC2replication factor C subunit 2 | Bardzo często (80–99%) | W 1 chorobie |
| RIT1Ras like without CAAX 1 | Bardzo często (80–99%) | W 1 chorobie |
| RNU4ATACRNA, U4atac small nuclear | Bardzo często (80–99%) | W 2 chorobach |
| RRASRAS related | Bardzo często (80–99%) | W 1 chorobie |
| RRAS2RAS related 2 | Bardzo często (80–99%) | W 1 chorobie |
| RUNX2RUNX family transcription factor 2 | Bardzo często (80–99%) | W 2 chorobach |
| SEC24DSEC24 homolog D, COPII component | Bardzo często (80–99%) | W 1 chorobie |
| SETD5SET domain containing 5 | Bardzo często (80–99%) | W 2 chorobach |
| SF3B2splicing factor 3b subunit 2 | Bardzo często (80–99%) | W 1 chorobie |
| SF3B4splicing factor 3b subunit 4 | Bardzo często (80–99%) | W 2 chorobach |
| SH3PXD2BSH3 and PX domains 2B | Bardzo często (80–99%) | W 1 chorobie |
| SHOXSHOX homeobox | Bardzo często (80–99%) | W 2 chorobach |
| SKISKI proto-oncogene | Bardzo często (80–99%) | W 2 chorobach |
| SLC10A7solute carrier family 10 member 7 | Bardzo często (80–99%) | W 1 chorobie |
| SLC18A3solute carrier family 18 member A3 | Bardzo często (80–99%) | W 1 chorobie |
| SLC25A19solute carrier family 25 member 19 | Bardzo często (80–99%) | W 2 chorobach |
| SLC26A2solute carrier family 26 member 2 | Bardzo często (80–99%) | W 5 chorobach |
| SMC1Astructural maintenance of chromosomes 1A | Bardzo często (80–99%) | W 2 chorobach |
| SMC3structural maintenance of chromosomes 3 | Bardzo często (80–99%) | W 2 chorobach |
| SNAPINSNAP associated protein | Bardzo często (80–99%) | W 1 chorobie |
| SNRPBsmall nuclear ribonucleoprotein polypeptides B and B1 | Bardzo często (80–99%) | W 2 chorobach |
| SOS1SOS Ras/Rac guanine nucleotide exchange factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| SOS2SOS Ras/Rho guanine nucleotide exchange factor 2 | Bardzo często (80–99%) | W 1 chorobie |
| SPRED2sprouty related EVH1 domain containing 2 | Bardzo często (80–99%) | W 1 chorobie |
| STX1Asyntaxin 1A | Bardzo często (80–99%) | W 1 chorobie |
| SUZ12SUZ12 polycomb repressive complex 2 subunit | Bardzo często (80–99%) | W 1 chorobie |
| TBL2transducin beta like 2 | Bardzo często (80–99%) | W 1 chorobie |
| TCTN3tectonic family member 3 | Bardzo często (80–99%) | W 4 chorobach |
| TGFBR1transforming growth factor beta receptor 1 | Bardzo często (80–99%) | W 2 chorobach |
| TMEM270transmembrane protein 270 | Bardzo często (80–99%) | W 1 chorobie |
| TRIP11thyroid hormone receptor interactor 11 | Bardzo często (80–99%) | W 1 chorobie |
| TRIP13thyroid hormone receptor interactor 13 | Bardzo często (80–99%) | W 1 chorobie |
| TRPS1transcriptional repressor GATA binding 1 | Bardzo często (80–99%) | W 2 chorobach |
| TUBA1Atubulin alpha 1a | Bardzo często (80–99%) | W 1 chorobie |
| UHRF1ubiquitin like with PHD and ring finger domains 1 | Bardzo często (80–99%) | W 1 chorobie |
| UPF3BUPF3B regulator of nonsense mediated mRNA decay | Bardzo często (80–99%) | W 1 chorobie |
| VPS37DVPS37D subunit of ESCRT-I | Bardzo często (80–99%) | W 1 chorobie |
| XRCC4X-ray repair cross complementing 4 | Bardzo często (80–99%) | W 1 chorobie |
| YARS2tyrosyl-tRNA synthetase 2 | Bardzo często (80–99%) | W 1 chorobie |
| ZBTB18zinc finger and BTB domain containing 18 | Bardzo często (80–99%) | W 2 chorobach |
| ZBTB24zinc finger and BTB domain containing 24 | Bardzo często (80–99%) | W 1 chorobie |
| ZDHHC9zDHHC palmitoyltransferase 9 | Bardzo często (80–99%) | W 1 chorobie |
| ABCD4ATP binding cassette subfamily D member 4 | Często (30–79%) | W 1 chorobie |
| ADAMTSL2ADAMTS like 2 | Często (30–79%) | W 1 chorobie |
| ADGRG6adhesion G protein-coupled receptor G6 | Często (30–79%) | W 1 chorobie |
| AEBP1AE binding protein 1 | Często (30–79%) | W 2 chorobach |
| AFF3ALF transcription elongation factor 3 | Często (30–79%) | W 1 chorobie |
| AHDC1AT-hook DNA binding motif containing 1 | Często (30–79%) | W 2 chorobach |
| ALDH1A2aldehyde dehydrogenase 1 family member A2 | Często (30–79%) | W 1 chorobie |
| ANAPC7anaphase promoting complex subunit 7 | Często (30–79%) | W 1 chorobie |
| ANKLE2ankyrin repeat and LEM domain containing 2 | Często (30–79%) | W 1 chorobie |
| ANKRD11ankyrin repeat domain 11 | Często (30–79%) | W 1 chorobie |
| ATP6AP2ATPase H+ transporting accessory protein 2 | Często (30–79%) | W 1 chorobie |
| ATP7AATPase copper transporting alpha | Często (30–79%) | W 1 chorobie |
| AUTS2activator of transcription and developmental regulator AUTS2 | Często (30–79%) | W 2 chorobach |
| B9D1B9 domain containing 1 | Często (30–79%) | W 1 chorobie |
| B9D2B9 domain containing 2 | Często (30–79%) | W 1 chorobie |
| BDNFbrain derived neurotrophic factor | Często (30–79%) | W 1 chorobie |
| BICD2BICD cargo adaptor 2 | Często (30–79%) | W 1 chorobie |
| BLMBLM RecQ like helicase | Często (30–79%) | W 1 chorobie |
| BPTFbromodomain PHD finger transcription factor | Często (30–79%) | W 2 chorobach |
| CAMTA1calmodulin binding transcription activator 1 | Często (30–79%) | W 1 chorobie |
| CASKcalcium/calmodulin dependent serine protein kinase | Często (30–79%) | W 2 chorobach |
| CC2D2Acoiled-coil and C2 domain containing 2A | Często (30–79%) | W 1 chorobie |
| CCDC32coiled-coil domain containing 32 | Często (30–79%) | W 1 chorobie |
| CEP290centrosomal protein 290 | Często (30–79%) | W 1 chorobie |
| CHD6chromodomain helicase DNA binding protein 6 | Często (30–79%) | W 1 chorobie |
| CHRNGcholinergic receptor nicotinic gamma subunit | Często (30–79%) | W 3 chorobach |
| COL11A2collagen type XI alpha 2 chain | Często (30–79%) | W 4 chorobach |
| COL12A1collagen type XII alpha 1 chain | Często (30–79%) | W 2 chorobach |
| COL1A1collagen type I alpha 1 chain | Często (30–79%) | W 2 chorobach |
| COL1A2collagen type I alpha 2 chain | Często (30–79%) | W 2 chorobach |
| COL2A1collagen type II alpha 1 chain | Często (30–79%) | W 5 chorobach |
| COL3A1collagen type III alpha 1 chain | Często (30–79%) | W 2 chorobach |
| COL6A1collagen type VI alpha 1 chain | Często (30–79%) | W 1 chorobie |
| COL6A3collagen type VI alpha 3 chain | Często (30–79%) | W 1 chorobie |
| COL9A1collagen type IX alpha 1 chain | Często (30–79%) | W 1 chorobie |
| COL9A2collagen type IX alpha 2 chain | Często (30–79%) | W 1 chorobie |
| COL9A3collagen type IX alpha 3 chain | Często (30–79%) | W 1 chorobie |
| COX7Bcytochrome c oxidase subunit 7B | Często (30–79%) | W 1 chorobie |
| CPLANE1ciliogenesis and planar polarity effector complex subunit 1 | Często (30–79%) | W 2 chorobach |
| CSPP1centrosome and spindle pole associated protein 1 | Często (30–79%) | W 2 chorobach |
| CTSKcathepsin K | Często (30–79%) | W 2 chorobach |
| D2HGDHD-2-hydroxyglutarate dehydrogenase | Często (30–79%) | W 1 chorobie |
| DICER1dicer 1, ribonuclease III | Często (30–79%) | W 1 chorobie |
| DONSONDNA replication fork stabilization factor DONSON | Często (30–79%) | W 2 chorobach |
| DPM2dolichyl-phosphate mannosyltransferase subunit 2, regulatory | Często (30–79%) | W 2 chorobach |
| DSTYKdual serine/threonine and tyrosine protein kinase | Często (30–79%) | W 1 chorobie |
| DVL1dishevelled segment polarity protein 1 | Często (30–79%) | W 3 chorobach |
| DVL3dishevelled segment polarity protein 3 | Często (30–79%) | W 2 chorobach |
| DYNC2H1dynein cytoplasmic 2 heavy chain 1 | Często (30–79%) | W 1 chorobie |
| DYNC2I1dynein 2 intermediate chain 1 | Często (30–79%) | W 1 chorobie |
| DYNC2I2dynein 2 intermediate chain 2 | Często (30–79%) | W 1 chorobie |
| EDN1endothelin 1 | Często (30–79%) | W 2 chorobach |
| EIF5Aeukaryotic translation initiation factor 5A | Często (30–79%) | W 1 chorobie |
| EMILIN1elastin microfibril interfacer 1 | Często (30–79%) | W 1 chorobie |
| EPG5ectopic P-granules 5 autophagy tethering factor | Często (30–79%) | W 1 chorobie |
| ESCO2establishment of sister chromatid cohesion N-acetyltransferase 2 | Często (30–79%) | W 2 chorobach |
| FAAP100FA core complex associated protein 100 | Często (30–79%) | W 2 chorobach |
| FAM149B1family with sequence similarity 149 member B1 | Często (30–79%) | W 1 chorobie |
| FANCLFA complementation group L | Często (30–79%) | W 2 chorobach |
| FASTKD5FASTK mitochondrial RNA regulator 5 | Często (30–79%) | W 1 chorobie |
| FAT4FAT atypical cadherin 4 | Często (30–79%) | W 2 chorobach |
| FBXO22F-box protein 22 | Często (30–79%) | W 1 chorobie |
| FDFT1farnesyl-diphosphate farnesyltransferase 1 | Często (30–79%) | W 1 chorobie |
| FGF3fibroblast growth factor 3 | Często (30–79%) | W 2 chorobach |
| FGFR1fibroblast growth factor receptor 1 | Często (30–79%) | W 1 chorobie |
| FGFRL1fibroblast growth factor receptor like 1 | Często (30–79%) | W 1 chorobie |
| FKRPfukutin related protein | Często (30–79%) | W 1 chorobie |
| FKTNfukutin | Często (30–79%) | W 1 chorobie |
| FOXC2forkhead box C2 | Często (30–79%) | W 1 chorobie |
| FOXI3forkhead box I3 | Często (30–79%) | W 1 chorobie |
| FZD2frizzled class receptor 2 | Często (30–79%) | W 3 chorobach |
| GABRA3gamma-aminobutyric acid type A receptor subunit alpha3 | Często (30–79%) | W 1 chorobie |
| GATA4GATA binding protein 4 | Często (30–79%) | W 1 chorobie |
| GEMIN4gem nuclear organelle associated protein 4 | Często (30–79%) | W 1 chorobie |
| GINS3GINS complex subunit 3 | Często (30–79%) | W 1 chorobie |
| GNAI3G protein subunit alpha i3 | Często (30–79%) | W 2 chorobach |
| GNB2G protein subunit beta 2 | Często (30–79%) | W 1 chorobie |
| GPC6glypican 6 | Często (30–79%) | W 2 chorobach |
| H4C9H4 clustered histone 9 | Często (30–79%) | W 1 chorobie |
| HBA1hemoglobin subunit alpha 1 | Często (30–79%) | W 1 chorobie |
| HBA2hemoglobin subunit alpha 2 | Często (30–79%) | W 1 chorobie |
| HCCSholocytochrome c synthase | Często (30–79%) | W 1 chorobie |
| HDAC9histone deacetylase 9 | Często (30–79%) | W 1 chorobie |
| HNRNPRheterogeneous nuclear ribonucleoprotein R | Często (30–79%) | W 1 chorobie |
| HNRNPUheterogeneous nuclear ribonucleoprotein U | Często (30–79%) | W 1 chorobie |
| HOXB1homeobox B1 | Często (30–79%) | W 1 chorobie |
| HSD17B4hydroxysteroid 17-beta dehydrogenase 4 | Często (30–79%) | W 1 chorobie |
| HYAL2hyaluronidase 2 | Często (30–79%) | W 1 chorobie |
| IFT43intraflagellar transport 43 | Często (30–79%) | W 2 chorobach |
| IFT80intraflagellar transport 80 | Często (30–79%) | W 1 chorobie |
| IPO8importin 8 | Często (30–79%) | W 2 chorobach |
| IRX5iroquois homeobox 5 | Często (30–79%) | W 1 chorobie |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Często (30–79%) | W 1 chorobie |
| KCNK9potassium two pore domain channel subfamily K member 9 | Często (30–79%) | W 1 chorobie |
| KDM6Alysine demethylase 6A | Często (30–79%) | W 2 chorobach |
| KIAA0753KIAA0753 | Często (30–79%) | W 1 chorobie |
| KIDINS220kinase D interacting substrate 220 | Często (30–79%) | W 1 chorobie |
| KIF14kinesin family member 14 | Często (30–79%) | W 1 chorobie |
| KLHL20kelch like family member 20 | Często (30–79%) | W 1 chorobie |
| KMT2Alysine methyltransferase 2A | Często (30–79%) | W 1 chorobie |
| KMT2Dlysine methyltransferase 2D | Często (30–79%) | W 2 chorobach |
| LAGE3L antigen family member 3 | Często (30–79%) | W 2 chorobach |
| LARGE1LARGE xylosyl- and glucuronyltransferase 1 | Często (30–79%) | W 1 chorobie |
| LBRlamin B receptor | Często (30–79%) | W 2 chorobach |
| LEMD2LEM domain nuclear envelope protein 2 | Często (30–79%) | W 1 chorobie |
| LIG4DNA ligase 4 | Często (30–79%) | W 1 chorobie |
| LOXL3lysyl oxidase like 3 | Często (30–79%) | W 1 chorobie |
| LRP4LDL receptor related protein 4 | Często (30–79%) | W 1 chorobie |
| LRRC32leucine rich repeat containing 32 | Często (30–79%) | W 1 chorobie |
| LTBP4latent transforming growth factor beta binding protein 4 | Często (30–79%) | W 1 chorobie |
| MCTP2multiple C2 and transmembrane domain containing 2 | Często (30–79%) | W 1 chorobie |
| MITFmelanocyte inducing transcription factor | Często (30–79%) | W 1 chorobie |
| MKS1MKS transition zone complex subunit 1 | Często (30–79%) | W 2 chorobach |
| MSTO1misato mitochondrial distribution and morphology regulator 1 | Często (30–79%) | W 2 chorobach |
| MTX2metaxin 2 | Często (30–79%) | W 1 chorobie |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Często (30–79%) | W 2 chorobach |
| MYO18Bmyosin XVIIIB | Często (30–79%) | W 1 chorobie |
| NCAPG2non-SMC condensin II complex subunit G2 | Często (30–79%) | W 1 chorobie |
| NDUFB11NADH:ubiquinone oxidoreductase subunit B11 | Często (30–79%) | W 1 chorobie |
| NEK1NIMA related kinase 1 | Często (30–79%) | W 2 chorobach |
| NEK9NIMA related kinase 9 | Często (30–79%) | W 1 chorobie |
| NFIXnuclear factor I X | Często (30–79%) | W 1 chorobie |
| NRCAMneuronal cell adhesion molecule | Często (30–79%) | W 1 chorobie |
| OFD1OFD1 centriole and centriolar satellite protein | Często (30–79%) | W 2 chorobach |
| PAX6paired box 6 | Często (30–79%) | W 1 chorobie |
| PDE6Dphosphodiesterase 6D | Często (30–79%) | W 1 chorobie |
| PEPDpeptidase D | Często (30–79%) | W 2 chorobach |
| PEX10peroxisomal biogenesis factor 10 | Często (30–79%) | W 1 chorobie |
| PEX11Bperoxisomal biogenesis factor 11 beta | Często (30–79%) | W 1 chorobie |
| PEX12peroxisomal biogenesis factor 12 | Często (30–79%) | W 1 chorobie |
| PEX13peroxisomal biogenesis factor 13 | Często (30–79%) | W 1 chorobie |
| PEX16peroxisomal biogenesis factor 16 | Często (30–79%) | W 1 chorobie |
| PEX19peroxisomal biogenesis factor 19 | Często (30–79%) | W 1 chorobie |
| PEX2peroxisomal biogenesis factor 2 | Często (30–79%) | W 2 chorobach |
| PEX26peroxisomal biogenesis factor 26 | Często (30–79%) | W 1 chorobie |
| PEX3peroxisomal biogenesis factor 3 | Często (30–79%) | W 2 chorobach |
| PEX5peroxisomal biogenesis factor 5 | Często (30–79%) | W 2 chorobach |
| PEX6peroxisomal biogenesis factor 6 | Często (30–79%) | W 1 chorobie |
| PHGDHphosphoglycerate dehydrogenase | Często (30–79%) | W 1 chorobie |
| PHIPPHIP subunit of CUL4-Ring ligase complex | Często (30–79%) | W 1 chorobie |
| PI4K2Aphosphatidylinositol 4-kinase type 2 alpha | Często (30–79%) | W 1 chorobie |
| PIGBphosphatidylinositol glycan anchor biosynthesis class B | Często (30–79%) | W 1 chorobie |
| PIGFphosphatidylinositol glycan anchor biosynthesis class F | Często (30–79%) | W 1 chorobie |
| PKDCCprotein kinase domain containing, cytoplasmic | Często (30–79%) | W 1 chorobie |
| PLAAphospholipase A2 activating protein | Często (30–79%) | W 2 chorobach |
| POLR1ARNA polymerase I subunit A | Często (30–79%) | W 1 chorobie |
| POMT1protein O-mannosyltransferase 1 | Często (30–79%) | W 1 chorobie |
| POMT2protein O-mannosyltransferase 2 | Często (30–79%) | W 1 chorobie |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Często (30–79%) | W 2 chorobach |
| PURApurine rich element binding protein A | Często (30–79%) | W 1 chorobie |
| PUS7pseudouridine synthase 7 | Często (30–79%) | W 1 chorobie |
| RAB18RAB18, member RAS oncogene family | Często (30–79%) | W 2 chorobach |
| RAB34RAB34, member RAS oncogene family | Często (30–79%) | W 1 chorobie |
| RAB3GAP1RAB3 GTPase activating protein catalytic subunit 1 | Często (30–79%) | W 3 chorobach |
| RAB3GAP2RAB3 GTPase activating non-catalytic protein subunit 2 | Często (30–79%) | W 3 chorobach |
| RAI1retinoic acid induced 1 | Często (30–79%) | W 3 chorobach |
| RB1RB transcriptional corepressor 1 | Często (30–79%) | W 1 chorobie |
| RDH11retinol dehydrogenase 11 | Często (30–79%) | W 1 chorobie |
| RFT1RFT1 glycolipid translocator homolog | Często (30–79%) | W 1 chorobie |
| RNU12RNA, U12 small nuclear | Często (30–79%) | W 1 chorobie |
| ROR2ROR family WNT receptor 2 | Często (30–79%) | W 2 chorobach |
| RPGRIP1RPGR interacting protein 1 | Często (30–79%) | W 1 chorobie |
| RPGRIP1LRPGRIP1 like | Często (30–79%) | W 1 chorobie |
| RPL17ribosomal protein L17 | Często (30–79%) | W 1 chorobie |
| RPL5ribosomal protein L5 | Często (30–79%) | W 2 chorobach |
| RSPO2R-spondin 2 | Często (30–79%) | W 2 chorobach |
| SCN4Asodium voltage-gated channel alpha subunit 4 | Często (30–79%) | W 2 chorobach |
| SLC25A24solute carrier family 25 member 24 | Często (30–79%) | W 1 chorobie |
| SLC2A10solute carrier family 2 member 10 | Często (30–79%) | W 1 chorobie |
| SMAD2SMAD family member 2 | Często (30–79%) | W 2 chorobach |
| SMAD3SMAD family member 3 | Często (30–79%) | W 1 chorobie |
| SPECC1Lsperm antigen with calponin homology and coiled-coil domains 1 like | Często (30–79%) | W 1 chorobie |
| SPEGstriated muscle enriched protein kinase | Często (30–79%) | W 1 chorobie |
| STRA6signaling receptor and transporter of retinol STRA6 | Często (30–79%) | W 1 chorobie |
| TBC1D20TBC1 domain family member 20 | Często (30–79%) | W 1 chorobie |
| TBCBtubulin folding cofactor B | Często (30–79%) | W 1 chorobie |
| TBX4T-box transcription factor 4 | Często (30–79%) | W 2 chorobach |
| TCTN1tectonic family member 1 | Często (30–79%) | W 1 chorobie |
| TCTN2tectonic family member 2 | Często (30–79%) | W 1 chorobie |
| TGFB2transforming growth factor beta 2 | Często (30–79%) | W 1 chorobie |
| TGFB3transforming growth factor beta 3 | Często (30–79%) | W 1 chorobie |
| TGFBR2transforming growth factor beta receptor 2 | Często (30–79%) | W 2 chorobach |
| TMEM107transmembrane protein 107 | Często (30–79%) | W 2 chorobach |
| TMEM216transmembrane protein 216 | Często (30–79%) | W 2 chorobach |
| TMEM231transmembrane protein 231 | Często (30–79%) | W 2 chorobach |
| TMEM237transmembrane protein 237 | Często (30–79%) | W 1 chorobie |
| TMEM67transmembrane protein 67 | Często (30–79%) | W 1 chorobie |
| TNNI2troponin I2, fast skeletal type | Często (30–79%) | W 2 chorobach |
| TNNT3troponin T3, fast skeletal type | Często (30–79%) | W 1 chorobie |
| TOE1target of EGR1, exonuclease | Często (30–79%) | W 2 chorobach |
| TOPORSTOP1 binding arginine/serine rich protein, E3 ubiquitin ligase | Często (30–79%) | W 1 chorobie |
| TPM2tropomyosin 2 | Często (30–79%) | W 4 chorobach |
| TRIOtrio Rho guanine nucleotide exchange factor | Często (30–79%) | W 2 chorobach |
| TRPM3transient receptor potential cation channel subfamily M member 3 | Często (30–79%) | W 1 chorobie |
| TWIST1twist family bHLH transcription factor 1 | Często (30–79%) | W 1 chorobie |
| TXNDC15thioredoxin domain containing 15 | Często (30–79%) | W 2 chorobach |
| TXNL4Athioredoxin like 4A | Często (30–79%) | W 1 chorobie |
| USB1U6 snRNA biogenesis phosphodiesterase 1 | Często (30–79%) | W 1 chorobie |
| VAC14VAC14 component of PIKFYVE complex | Często (30–79%) | W 1 chorobie |
| VARS1valyl-tRNA synthetase 1 | Często (30–79%) | W 1 chorobie |
| WDR26WD repeat domain 26 | Często (30–79%) | W 2 chorobach |
| WDR35WD repeat domain 35 | Często (30–79%) | W 2 chorobach |
| WLSWnt ligand secretion mediator | Często (30–79%) | W 1 chorobie |
| WNT3Wnt family member 3 | Często (30–79%) | W 2 chorobach |
| WNT5AWnt family member 5A | Często (30–79%) | W 2 chorobach |
| WNT7AWnt family member 7A | Często (30–79%) | W 1 chorobie |
| WSB2WD repeat and SOCS box containing 2 | Często (30–79%) | W 1 chorobie |
| WT1WT1 transcription factor | Często (30–79%) | W 1 chorobie |
| ZNF292zinc finger protein 292 | Często (30–79%) | W 1 chorobie |
| ZNF668zinc finger protein 668 | Często (30–79%) | W 1 chorobie |
| ABCD1ATP binding cassette subfamily D member 1 | Czasami (5–29%) | W 1 chorobie |
| ACTA1actin alpha 1, skeletal muscle | Czasami (5–29%) | W 4 chorobach |
| ACTG2actin gamma 2, smooth muscle | Czasami (5–29%) | W 1 chorobie |
| ADAT3adenosine deaminase tRNA specific 3 | Czasami (5–29%) | W 1 chorobie |
| ADGRG1adhesion G protein-coupled receptor G1 | Czasami (5–29%) | W 1 chorobie |
| AFF4ALF transcription elongation factor 4 | Czasami (5–29%) | W 1 chorobie |
| ALG12ALG12 alpha-1,6-mannosyltransferase | Czasami (5–29%) | W 1 chorobie |
| ALG14ALG14 UDP-N-acetylglucosaminyltransferase subunit | Czasami (5–29%) | W 1 chorobie |
| ALPK3alpha kinase 3 | Czasami (5–29%) | W 1 chorobie |
| AMER1APC membrane recruitment protein 1 | Czasami (5–29%) | W 2 chorobach |
| APCAPC regulator of Wnt signaling pathway | Czasami (5–29%) | W 1 chorobie |
| ARID1BAT-rich interaction domain 1B | Czasami (5–29%) | W 1 chorobie |
| ARL6IP6ARF like GTPase 6 interacting protein 6 | Czasami (5–29%) | W 1 chorobie |
| ARMC9armadillo repeat containing 9 | Czasami (5–29%) | W 1 chorobie |
| ARVCFARVCF delta catenin family member | Czasami (5–29%) | W 1 chorobie |
| ARXaristaless related homeobox | Czasami (5–29%) | W 2 chorobach |
| ASXL1ASXL transcriptional regulator 1 | Czasami (5–29%) | W 2 chorobach |
| ASXL3ASXL transcriptional regulator 3 | Czasami (5–29%) | W 1 chorobie |
| ATAD3AATPase family AAA domain containing 3A | Czasami (5–29%) | W 3 chorobach |
| ATP6V1B2ATPase H+ transporting V1 subunit B2 | Czasami (5–29%) | W 1 chorobie |
| B3GAT3beta-1,3-glucuronyltransferase 3 | Czasami (5–29%) | W 1 chorobie |
| B4GALT7beta-1,4-galactosyltransferase 7 | Czasami (5–29%) | W 1 chorobie |
| BCAP31B cell receptor associated protein 31 | Czasami (5–29%) | W 1 chorobie |
| BCL11ABCL11 transcription factor A | Czasami (5–29%) | W 1 chorobie |
| BICRABRD4 interacting chromatin remodeling complex associated protein | Czasami (5–29%) | W 1 chorobie |
| BRAT1BRCA1 associated ATM activator 1 | Czasami (5–29%) | W 1 chorobie |
| BRCA1BRCA1 DNA repair associated | Czasami (5–29%) | W 1 chorobie |
| BRCA2BRCA2 DNA repair associated | Czasami (5–29%) | W 1 chorobie |
| BRF1BRF1 general transcription factor IIIB subunit | Czasami (5–29%) | W 1 chorobie |
| BRIP1BRCA1 interacting DNA helicase 1 | Czasami (5–29%) | W 1 chorobie |
| CA2carbonic anhydrase 2 | Czasami (5–29%) | W 1 chorobie |
| CAPRIN1cell cycle associated protein 1 | Czasami (5–29%) | W 1 chorobie |
| CCDC22CCC complex scaffolding subunit CCDC22 | Czasami (5–29%) | W 1 chorobie |
| CDC42BPBCDC42 binding protein kinase beta | Czasami (5–29%) | W 1 chorobie |
| CFL2cofilin 2 | Czasami (5–29%) | W 1 chorobie |
| CHD5chromodomain helicase DNA binding protein 5 | Czasami (5–29%) | W 1 chorobie |
| CHD8chromodomain helicase DNA binding protein 8 | Czasami (5–29%) | W 1 chorobie |
| CHN1chimerin 1 | Czasami (5–29%) | W 1 chorobie |
| CHST3carbohydrate sulfotransferase 3 | Czasami (5–29%) | W 1 chorobie |
| CHSY1chondroitin sulfate synthase 1 | Czasami (5–29%) | W 1 chorobie |
| CLCF1cardiotrophin like cytokine factor 1 | Czasami (5–29%) | W 1 chorobie |
| CLCN3Cl-/H+ antiporter 3 | Czasami (5–29%) | W 1 chorobie |
| CLPBClpB family mitochondrial disaggregase | Czasami (5–29%) | W 1 chorobie |
| CLTCL1clathrin heavy chain like 1 | Czasami (5–29%) | W 1 chorobie |
| CNTNAP1contactin associated protein 1 | Czasami (5–29%) | W 2 chorobach |
| COASYCoenzyme A synthase | Czasami (5–29%) | W 1 chorobie |
| COL25A1collagen type XXV alpha 1 chain | Czasami (5–29%) | W 1 chorobie |
| COL5A1collagen type V alpha 1 chain | Czasami (5–29%) | W 1 chorobie |
| COMTcatechol-O-methyltransferase | Czasami (5–29%) | W 1 chorobie |
| CRELD1CRELD disulfide isomerase 1 | Czasami (5–29%) | W 1 chorobie |
| CRLF1cytokine receptor like factor 1 | Czasami (5–29%) | W 2 chorobach |
| CSNK2A1casein kinase 2 alpha 1 | Czasami (5–29%) | W 1 chorobie |
| CTNNB1catenin beta 1 | Czasami (5–29%) | W 1 chorobie |
| DKC1dyskerin pseudouridine synthase 1 | Czasami (5–29%) | W 1 chorobie |
| DLK1delta like non-canonical Notch ligand 1 | Czasami (5–29%) | W 4 chorobach |
| DOT1LDOT1 like histone lysine methyltransferase | Czasami (5–29%) | W 1 chorobie |
| DPH2diphthamide biosynthesis 2 | Czasami (5–29%) | W 1 chorobie |
| DPH5diphthamide biosynthesis 5 | Czasami (5–29%) | W 1 chorobie |
| DPM1dolichyl-phosphate mannosyltransferase subunit 1, catalytic | Czasami (5–29%) | W 2 chorobach |
| DPYDdihydropyrimidine dehydrogenase | Czasami (5–29%) | W 1 chorobie |
| DPYSL5dihydropyrimidinase like 5 | Czasami (5–29%) | W 1 chorobie |
| EBF3EBF transcription factor 3 | Czasami (5–29%) | W 1 chorobie |
| EEFSECeukaryotic elongation factor, selenocysteine-tRNA specific | Czasami (5–29%) | W 1 chorobie |
| EMC1ER membrane protein complex subunit 1 | Czasami (5–29%) | W 2 chorobach |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| ERGIC1endoplasmic reticulum-golgi intermediate compartment 1 | Czasami (5–29%) | W 1 chorobie |
| EYA1EYA transcriptional coactivator and phosphatase 1 | Czasami (5–29%) | W 1 chorobie |
| FANCAFA complementation group A | Czasami (5–29%) | W 1 chorobie |
| FANCBFA complementation group B | Czasami (5–29%) | W 2 chorobach |
| FANCCFA complementation group C | Czasami (5–29%) | W 1 chorobie |
| FANCD2FA complementation group D2 | Czasami (5–29%) | W 1 chorobie |
| FANCEFA complementation group E | Czasami (5–29%) | W 1 chorobie |
| FANCFFA complementation group F | Czasami (5–29%) | W 1 chorobie |
| FANCGFA complementation group G | Czasami (5–29%) | W 1 chorobie |
| FANCIFA complementation group I | Czasami (5–29%) | W 1 chorobie |
| FANCMFA complementation group M | Czasami (5–29%) | W 1 chorobie |
| FBN2fibrillin 2 | Czasami (5–29%) | W 1 chorobie |
| FBXL4F-box and leucine rich repeat protein 4 | Czasami (5–29%) | W 1 chorobie |
| FBXO11F-box protein 11 | Czasami (5–29%) | W 1 chorobie |
| FBXW11F-box and WD repeat domain containing 11 | Czasami (5–29%) | W 1 chorobie |
| FOCADfocadhesin | Czasami (5–29%) | W 1 chorobie |
| FOXF1forkhead box F1 | Czasami (5–29%) | W 1 chorobie |
| GATAD2BGATA zinc finger domain containing 2B | Czasami (5–29%) | W 1 chorobie |
| GDF11growth differentiation factor 11 | Czasami (5–29%) | W 1 chorobie |
| GJA5gap junction protein alpha 5 | Czasami (5–29%) | W 1 chorobie |
| GJA8gap junction protein alpha 8 | Czasami (5–29%) | W 1 chorobie |
| GNA11G protein subunit alpha 11 | Czasami (5–29%) | W 1 chorobie |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Czasami (5–29%) | W 1 chorobie |
| GON7GON7 subunit of KEOPS complex | Czasami (5–29%) | W 1 chorobie |
| GP1BBglycoprotein Ib platelet subunit beta | Czasami (5–29%) | W 1 chorobie |
| GPKOWG-patch domain and KOW motifs | Czasami (5–29%) | W 1 chorobie |
| GTF3C3general transcription factor IIIC subunit 3 | Czasami (5–29%) | W 1 chorobie |
| H3-3AH3.3 histone A | Czasami (5–29%) | W 1 chorobie |
| HACD13-hydroxyacyl-CoA dehydratase 1 | Czasami (5–29%) | W 1 chorobie |
| HDAC6histone deacetylase 6 | Czasami (5–29%) | W 1 chorobie |
| HEATR3HEAT repeat containing 3 | Czasami (5–29%) | W 2 chorobach |
| HECTD4HECT domain E3 ubiquitin protein ligase 4 | Czasami (5–29%) | W 1 chorobie |
| HIRAhistone cell cycle regulator | Czasami (5–29%) | W 1 chorobie |
| HNRNPH2heterogeneous nuclear ribonucleoprotein H2 | Czasami (5–29%) | W 1 chorobie |
| IQSEC2IQ motif and Sec7 domain ArfGEF 2 | Czasami (5–29%) | W 1 chorobie |
| ITGA7integrin subunit alpha 7 | Czasami (5–29%) | W 1 chorobie |
| JMJD1Cjumonji domain containing 1C | Czasami (5–29%) | W 1 chorobie |
| KBTBD13kelch repeat and BTB domain containing 13 | Czasami (5–29%) | W 1 chorobie |
| KCNH1potassium voltage-gated channel subfamily H member 1 | Czasami (5–29%) | W 1 chorobie |
| KCNN3potassium calcium-activated channel subfamily N member 3 | Czasami (5–29%) | W 1 chorobie |
| KDM4Blysine demethylase 4B | Czasami (5–29%) | W 1 chorobie |
| KDM5Alysine demethylase 5A | Czasami (5–29%) | W 1 chorobie |
| KDM5Clysine demethylase 5C | Czasami (5–29%) | W 1 chorobie |
| KIAA0586KIAA0586 | Czasami (5–29%) | W 1 chorobie |
| KIF26Akinesin family member 26A | Czasami (5–29%) | W 1 chorobie |
| KLHL40kelch like family member 40 | Czasami (5–29%) | W 1 chorobie |
| KLHL41kelch like family member 41 | Czasami (5–29%) | W 4 chorobach |
| LEMD3LEM domain containing 3 | Czasami (5–29%) | W 1 chorobie |
| LGI1leucine rich glioma inactivated 1 | Czasami (5–29%) | W 1 chorobie |
| LMBRD2LMBR1 domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| LMOD3leiomodin 3 | Czasami (5–29%) | W 2 chorobach |
| LRPPRCleucine rich pentatricopeptide repeat containing | Czasami (5–29%) | W 1 chorobie |
| MAB21L1mab-21 like 1 | Czasami (5–29%) | W 1 chorobie |
| MAD2L2mitotic arrest deficient 2 like 2 | Czasami (5–29%) | W 1 chorobie |
| MADDMAP kinase activating death domain | Czasami (5–29%) | W 1 chorobie |
| MAP3K20mitogen-activated protein kinase kinase kinase 20 | Czasami (5–29%) | W 1 chorobie |
| MAPK1mitogen-activated protein kinase 1 | Czasami (5–29%) | W 1 chorobie |
| MAPRE2microtubule associated protein RP/EB family member 2 | Czasami (5–29%) | W 2 chorobach |
| MEG3maternally expressed 3 | Czasami (5–29%) | W 4 chorobach |
| MID1midline 1 | Czasami (5–29%) | W 1 chorobie |
| MIPEPmitochondrial intermediate peptidase | Czasami (5–29%) | W 1 chorobie |
| MYBPC1myosin binding protein C1 | Czasami (5–29%) | W 1 chorobie |
| MYL2myosin light chain 2 | Czasami (5–29%) | W 1 chorobie |
| MYPNmyopalladin | Czasami (5–29%) | W 1 chorobie |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| NEBnebulin | Czasami (5–29%) | W 3 chorobach |
| NEDD4LNEDD4 like E3 ubiquitin protein ligase | Czasami (5–29%) | W 1 chorobie |
| NF1neurofibromin 1 | Czasami (5–29%) | W 1 chorobie |
| NSDHLNAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL | Czasami (5–29%) | W 2 chorobach |
| NUP133nucleoporin 133 | Czasami (5–29%) | W 1 chorobie |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Czasami (5–29%) | W 1 chorobie |
| OSGEPO-sialoglycoprotein endopeptidase | Czasami (5–29%) | W 2 chorobach |
| PAHphenylalanine hydroxylase | Czasami (5–29%) | W 1 chorobie |
| PALB2partner and localizer of BRCA2 | Czasami (5–29%) | W 1 chorobie |
| PAX7paired box 7 | Czasami (5–29%) | W 1 chorobie |
| PDE4Dphosphodiesterase 4D | Czasami (5–29%) | W 1 chorobie |
| PDGFRBplatelet derived growth factor receptor beta | Czasami (5–29%) | W 1 chorobie |
| PGAP2post-GPI attachment to proteins 2 | Czasami (5–29%) | W 1 chorobie |
| PGAP3post-GPI attachment to proteins phospholipase 3 | Czasami (5–29%) | W 1 chorobie |
| PGM1phosphoglucomutase 1 | Czasami (5–29%) | W 1 chorobie |
| PIEZO1piezo type mechanosensitive ion channel component 1 (Er blood group) | Czasami (5–29%) | W 1 chorobie |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Czasami (5–29%) | W 1 chorobie |
| PIGOphosphatidylinositol glycan anchor biosynthesis class O | Czasami (5–29%) | W 1 chorobie |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Czasami (5–29%) | W 1 chorobie |
| PIGVphosphatidylinositol glycan anchor biosynthesis class V | Czasami (5–29%) | W 1 chorobie |
| PIGWphosphatidylinositol glycan anchor biosynthesis class W | Czasami (5–29%) | W 1 chorobie |
| PIGYphosphatidylinositol glycan anchor biosynthesis class Y | Czasami (5–29%) | W 1 chorobie |
| PLXND1plexin D1 | Czasami (5–29%) | W 1 chorobie |
| POGZpogo transposable element derived with ZNF domain | Czasami (5–29%) | W 1 chorobie |
| POLEDNA polymerase epsilon, catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| PPP1R12Aprotein phosphatase 1 regulatory subunit 12A | Czasami (5–29%) | W 1 chorobie |
| PPP1R15Bprotein phosphatase 1 regulatory subunit 15B | Czasami (5–29%) | W 2 chorobach |
| PRIM1DNA primase subunit 1 | Czasami (5–29%) | W 1 chorobie |
| PRUNE1prune exopolyphosphatase 1 | Czasami (5–29%) | W 1 chorobie |
| PSPHphosphoserine phosphatase | Czasami (5–29%) | W 1 chorobie |
| PTENphosphatase and tensin homolog | Czasami (5–29%) | W 2 chorobach |
| PUF60poly(U) binding splicing factor 60 | Czasami (5–29%) | W 1 chorobie |
| PYROXD1pyridine nucleotide-disulphide oxidoreductase domain 1 | Czasami (5–29%) | W 1 chorobie |
| RAD51RAD51 recombinase | Czasami (5–29%) | W 1 chorobie |
| RAD51CRAD51 paralog C | Czasami (5–29%) | W 1 chorobie |
| RAP1BRAP1B, member of RAS oncogene family | Czasami (5–29%) | W 1 chorobie |
| RBM8ARNA binding motif protein 8A | Czasami (5–29%) | W 2 chorobach |
| RBMXRNA binding motif protein X-linked | Czasami (5–29%) | W 1 chorobie |
| REREarginine-glutamic acid dipeptide repeats | Czasami (5–29%) | W 2 chorobach |
| REV3LREV3 like, DNA directed polymerase zeta catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| RFWD3ring finger and WD repeat domain 3 | Czasami (5–29%) | W 1 chorobie |
| RHOBTB2Rho related BTB domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| RNU4-2RNA, U4 small nuclear 2 | Czasami (5–29%) | W 1 chorobie |
| RPS26ribosomal protein S26 | Czasami (5–29%) | W 2 chorobach |
| RREB1ras responsive element binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| RTL1retrotransposon Gag like 1 | Czasami (5–29%) | W 4 chorobach |
| SALL4spalt like transcription factor 4 | Czasami (5–29%) | W 1 chorobie |
| SEC24CSEC24 homolog C, COPII component | Czasami (5–29%) | W 1 chorobie |
| SELENONselenoprotein N | Czasami (5–29%) | W 1 chorobie |
| SETBP1SET binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| SH2B1SH2B adaptor protein 1 | Czasami (5–29%) | W 1 chorobie |
| SHANK3SH3 and multiple ankyrin repeat domains 3 | Czasami (5–29%) | W 1 chorobie |
| SIM1SIM bHLH transcription factor 1 | Czasami (5–29%) | W 1 chorobie |
| SIX1SIX homeobox 1 | Czasami (5–29%) | W 1 chorobie |
| SLC6A1solute carrier family 6 member 1 | Czasami (5–29%) | W 1 chorobie |
| SLC6A11solute carrier family 6 member 11 | Czasami (5–29%) | W 1 chorobie |
| SLX4SLX4 structure-specific endonuclease subunit | Czasami (5–29%) | W 2 chorobach |
| SMC5structural maintenance of chromosomes 5 | Czasami (5–29%) | W 1 chorobie |
| SMG8SMG8 nonsense mediated mRNA decay factor | Czasami (5–29%) | W 1 chorobie |
| SMOC1SPARC related modular calcium binding 1 | Czasami (5–29%) | W 1 chorobie |
| SNIP1Smad nuclear interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Czasami (5–29%) | W 1 chorobie |
| SOX6SRY-box transcription factor 6 | Czasami (5–29%) | W 1 chorobie |
| SPENspen family transcriptional repressor | Czasami (5–29%) | W 1 chorobie |
| SPOPspeckle type BTB/POZ protein | Czasami (5–29%) | W 1 chorobie |
| SRPX2sushi repeat containing protein X-linked 2 | Czasami (5–29%) | W 1 chorobie |
| SRYsex determining region Y | Czasami (5–29%) | W 1 chorobie |
| STAG1STAG1 cohesin complex component | Czasami (5–29%) | W 1 chorobie |
| STAG2STAG2 cohesin complex component | Czasami (5–29%) | W 2 chorobach |
| SUPT16HSPT16 homolog, facilitates chromatin remodeling subunit | Czasami (5–29%) | W 1 chorobie |
| TAF1TATA-box binding protein associated factor 1 | Czasami (5–29%) | W 1 chorobie |
| TBC1D32TBC1 domain family member 32 | Czasami (5–29%) | W 1 chorobie |
| TBCDtubulin folding cofactor D | Czasami (5–29%) | W 2 chorobach |
| TBCKTBC1 domain containing kinase | Czasami (5–29%) | W 1 chorobie |
| TBX1T-box transcription factor 1 | Czasami (5–29%) | W 3 chorobach |
| THOC6THO complex subunit 6 | Czasami (5–29%) | W 1 chorobie |
| TNRC6Btrinucleotide repeat containing adaptor 6B | Czasami (5–29%) | W 1 chorobie |
| TP53RKTP53 regulating kinase | Czasami (5–29%) | W 1 chorobie |
| TPM3tropomyosin 3 | Czasami (5–29%) | W 2 chorobach |
| TPRKBTP53RK binding protein | Czasami (5–29%) | W 1 chorobie |
| TRMT10AtRNA methyltransferase 10A | Czasami (5–29%) | W 1 chorobie |
| TSEN54tRNA splicing endonuclease subunit 54 | Czasami (5–29%) | W 1 chorobie |
| TUBBtubulin beta class I | Czasami (5–29%) | W 2 chorobach |
| TUBB3tubulin beta 3 class III | Czasami (5–29%) | W 1 chorobie |
| TWIST2twist family bHLH transcription factor 2 | Czasami (5–29%) | W 1 chorobie |
| UBE2Tubiquitin conjugating enzyme E2 T | Czasami (5–29%) | W 1 chorobie |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Czasami (5–29%) | W 1 chorobie |
| WASHC5WASH complex subunit 5 | Czasami (5–29%) | W 2 chorobach |
| WDR4WDR4 tRNA N7-guanosine methyltransferase non-catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| WDR62WD repeat domain 62 | Czasami (5–29%) | W 1 chorobie |
| WDR73WD repeat domain 73 | Czasami (5–29%) | W 2 chorobach |
| WDR83OSWD repeat domain 83 opposite strand | Czasami (5–29%) | W 1 chorobie |
| WWOXWW domain containing oxidoreductase | Czasami (5–29%) | W 1 chorobie |
| XRCC2X-ray repair cross complementing 2 | Czasami (5–29%) | W 1 chorobie |
| YRDCyrdC N6-threonylcarbamoyltransferase domain containing | Czasami (5–29%) | W 1 chorobie |
| YY1YY1 transcription factor | Czasami (5–29%) | W 2 chorobach |
| ZFXzinc finger protein X-linked | Czasami (5–29%) | W 1 chorobie |
| ZNF699zinc finger protein 699 | Czasami (5–29%) | W 1 chorobie |
| ZRSR2zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | Czasami (5–29%) | W 1 chorobie |
| ADA2adenosine deaminase 2 | Rzadko (1–4%) | W 1 chorobie |
| AFG2BAAA ATPase AFG2B | Rzadko (1–4%) | W 1 chorobie |
| DZIP1LDAZ interacting zinc finger protein 1 like | Rzadko (1–4%) | W 1 chorobie |
| FGF10fibroblast growth factor 10 | Rzadko (1–4%) | W 1 chorobie |
| FGFR3fibroblast growth factor receptor 3 | Rzadko (1–4%) | W 1 chorobie |
| GATA1GATA binding protein 1 | Rzadko (1–4%) | W 1 chorobie |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Rzadko (1–4%) | W 1 chorobie |
| PPP2R5Cprotein phosphatase 2 regulatory subunit B'gamma | Rzadko (1–4%) | W 1 chorobie |
| PTBP1polypyrimidine tract binding protein 1 | Rzadko (1–4%) | W 1 chorobie |
| RPL11ribosomal protein L11 | Rzadko (1–4%) | W 1 chorobie |
| RPL15ribosomal protein L15 | Rzadko (1–4%) | W 1 chorobie |
| RPL18ribosomal protein L18 | Rzadko (1–4%) | W 1 chorobie |
| RPL26ribosomal protein L26 | Rzadko (1–4%) | W 1 chorobie |
| RPL27ribosomal protein L27 | Rzadko (1–4%) | W 1 chorobie |
| RPL31ribosomal protein L31 | Rzadko (1–4%) | W 1 chorobie |
| RPL35ribosomal protein L35 | Rzadko (1–4%) | W 1 chorobie |
| RPL35Aribosomal protein L35a | Rzadko (1–4%) | W 1 chorobie |
| RPL8ribosomal protein L8 | Rzadko (1–4%) | W 1 chorobie |
| RPL9ribosomal protein L9 | Rzadko (1–4%) | W 1 chorobie |
| RPS10ribosomal protein S10 | Rzadko (1–4%) | W 1 chorobie |
| RPS15Aribosomal protein S15a | Rzadko (1–4%) | W 1 chorobie |
| RPS17ribosomal protein S17 | Rzadko (1–4%) | W 1 chorobie |
| RPS19ribosomal protein S19 | Rzadko (1–4%) | W 2 chorobach |
| RPS20ribosomal protein S20 | Rzadko (1–4%) | W 1 chorobie |
| RPS24ribosomal protein S24 | Rzadko (1–4%) | W 1 chorobie |
| RPS27ribosomal protein S27 | Rzadko (1–4%) | W 1 chorobie |
| RPS29ribosomal protein S29 | Rzadko (1–4%) | W 1 chorobie |
| RPS7ribosomal protein S7 | Rzadko (1–4%) | W 1 chorobie |
| ASNSasparagine synthetase (glutamine-hydrolyzing) | Nie odnotowano | W 1 chorobie |
| ATRXATRX chromatin remodeler | Nie odnotowano | W 1 chorobie |
| BCL11BBCL11 transcription factor B | Nie odnotowano | W 1 chorobie |
| BMP4bone morphogenetic protein 4 | Nie odnotowano | W 1 chorobie |
| BMPERBMP binding endothelial regulator | Nie odnotowano | W 1 chorobie |
| C12orf57chromosome 12 open reading frame 57 | Nie odnotowano | W 1 chorobie |
| C2CD3C2 domain containing 3 centriole elongation regulator | Nie odnotowano | W 1 chorobie |
| CCN2cellular communication network factor 2 | Nie odnotowano | W 1 chorobie |
| CENPFcentromere protein F | Nie odnotowano | W 1 chorobie |
| CHD7chromodomain helicase DNA binding protein 7 | Nie odnotowano | W 1 chorobie |
| CHRNA1cholinergic receptor nicotinic alpha 1 subunit | Nie odnotowano | W 2 chorobach |
| CHRNDcholinergic receptor nicotinic delta subunit | Nie odnotowano | W 1 chorobie |
| DDR2discoidin domain receptor tyrosine kinase 2 | Nie odnotowano | W 1 chorobie |
| DNAJC21DnaJ heat shock protein family (Hsp40) member C21 | Nie odnotowano | W 1 chorobie |
| DOCK6dedicator of cytokinesis 6 | Nie odnotowano | W 1 chorobie |
| DPAGT1dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 | Nie odnotowano | W 1 chorobie |
| ECEL1endothelin converting enzyme like 1 | Nie odnotowano | W 1 chorobie |
| EDNRAendothelin receptor type A | Nie odnotowano | W 1 chorobie |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Nie odnotowano | W 1 chorobie |
| FLCNfolliculin | Nie odnotowano | W 1 chorobie |
| FLVCR2FLVCR choline and putative heme transporter 2 | Nie odnotowano | W 1 chorobie |
| GBA1glucosylceramidase beta 1 | Nie odnotowano | W 1 chorobie |
| GNPATglyceronephosphate O-acyltransferase | Nie odnotowano | W 1 chorobie |
| HRASHRas proto-oncogene, GTPase | Nie odnotowano | W 1 chorobie |
| HUWE1HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 | Nie odnotowano | W 1 chorobie |
| IDUAalpha-L-iduronidase | Nie odnotowano | W 1 chorobie |
| IGF1Rinsulin like growth factor 1 receptor | Nie odnotowano | W 1 chorobie |
| KNL1kinetochore scaffold 1 | Nie odnotowano | W 1 chorobie |
| MAP2K1mitogen-activated protein kinase kinase 1 | Nie odnotowano | W 2 chorobach |
| MAP2K2mitogen-activated protein kinase kinase 2 | Nie odnotowano | W 1 chorobie |
| MBD5methyl-CpG binding domain protein 5 | Nie odnotowano | W 1 chorobie |
| MECP2methyl-CpG binding protein 2 | Nie odnotowano | W 1 chorobie |
| MMP2matrix metallopeptidase 2 | Nie odnotowano | W 1 chorobie |
| MYH8myosin heavy chain 8 | Nie odnotowano | W 1 chorobie |
| OSTM1osteoclastogenesis associated transmembrane protein 1 | Nie odnotowano | W 1 chorobie |
| PEX7peroxisomal biogenesis factor 7 | Nie odnotowano | W 1 chorobie |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Nie odnotowano | W 1 chorobie |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Nie odnotowano | W 1 chorobie |
| PLA2G6phospholipase A2 group VI | Nie odnotowano | W 1 chorobie |
| PRRX1paired related homeobox 1 | Nie odnotowano | W 1 chorobie |
| PTDSS1phosphatidylserine synthase 1 | Nie odnotowano | W 1 chorobie |
| RAB23RAB23, member RAS oncogene family | Nie odnotowano | W 1 chorobie |
| RARBretinoic acid receptor beta | Nie odnotowano | W 1 chorobie |
| RLIMring finger protein, LIM domain interacting | Nie odnotowano | W 1 chorobie |
| SMOsmoothened, frizzled class receptor | Nie odnotowano | W 1 chorobie |
| SPRED1sprouty related EVH1 domain containing 1 | Nie odnotowano | W 1 chorobie |
| SSR4signal sequence receptor subunit 4 | Nie odnotowano | W 1 chorobie |
| TAPT1transmembrane anterior posterior transformation 1 | Nie odnotowano | W 1 chorobie |
| TBX15T-box transcription factor 15 | Nie odnotowano | W 1 chorobie |
| TENT5Aterminal nucleotidyltransferase 5A | Nie odnotowano | W 1 chorobie |
| TFAP2Atranscription factor AP-2 alpha | Nie odnotowano | W 1 chorobie |
| TMCO1transmembrane and coiled-coil domains 1 | Nie odnotowano | W 1 chorobie |
| TRRAPtransformation/transcription domain associated protein | Nie odnotowano | W 1 chorobie |
| UBA1ubiquitin like modifier activating enzyme 1 | Nie odnotowano | W 1 chorobie |
| VPS33BVPS33B late endosome and lysosome associated | Nie odnotowano | W 1 chorobie |
| ZC4H2zinc finger C4H2-type containing | Nie odnotowano | W 1 chorobie |
| ZMIZ1zinc finger MIZ-type containing 1 | Nie odnotowano | W 1 chorobie |
| ZNF335zinc finger protein 335 | Nie odnotowano | W 1 chorobie |
| ZNF341zinc finger protein 341 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni